320 related articles for article (PubMed ID: 26206573)
1. New therapies for hepatic fibrosis.
Koyama Y; Brenner DA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
[TBL] [Abstract][Full Text] [Related]
2. New Developments on the Treatment of Liver Fibrosis.
Koyama Y; Xu J; Liu X; Brenner DA
Dig Dis; 2016; 34(5):589-96. PubMed ID: 27332862
[TBL] [Abstract][Full Text] [Related]
3. Anti-fibrogenic strategies and the regression of fibrosis.
Kisseleva T; Brenner DA
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):305-17. PubMed ID: 21497747
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
Kim WH; Matsumoto K; Bessho K; Nakamura T
Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
[TBL] [Abstract][Full Text] [Related]
5. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
6. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
8. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
de Oliveira da Silva B; Ramos LF; Moraes KCM
Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
[TBL] [Abstract][Full Text] [Related]
9. Origin and function of myofibroblasts in the liver.
Wells RG; Schwabe RF
Semin Liver Dis; 2015 May; 35(2):97-106. PubMed ID: 25974896
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic treatments for chronic liver diseases: The present and the future.
Odagiri N; Matsubara T; Sato-Matsubara M; Fujii H; Enomoto M; Kawada N
Clin Mol Hepatol; 2021 Jul; 27(3):413-424. PubMed ID: 33317250
[TBL] [Abstract][Full Text] [Related]
11. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
[TBL] [Abstract][Full Text] [Related]
12. The origin of fibrogenic myofibroblasts in fibrotic liver.
Kisseleva T
Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
14. Human Hepatic Stellate Cells: Isolation and Characterization.
Liu X; Brenner DA; Kisseleva T
Methods Mol Biol; 2023; 2669():221-232. PubMed ID: 37247063
[TBL] [Abstract][Full Text] [Related]
15. Testing Cell Migration, Invasion, Proliferation, and Apoptosis in Hepatic Stellate Cells.
Wankell M; Hebbard L
Methods Mol Biol; 2023; 2669():43-54. PubMed ID: 37247053
[TBL] [Abstract][Full Text] [Related]
16. Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
Bansal R; Nagórniewicz B; Prakash J
Mediators Inflamm; 2016; 2016():7629724. PubMed ID: 27999454
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L
Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
[TBL] [Abstract][Full Text] [Related]
18. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
19. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
20. Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.
Sun WY; Song Y; Hu SS; Wang QT; Wu HX; Chen JY; Wei W
J Cell Biochem; 2013 May; 114(5):1153-62. PubMed ID: 23192415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
